Australia markets close in 5 hours 19 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
72.45-0.54 (-0.74%)
At close: 04:00PM EST
72.75 +0.30 (+0.41%)
After hours: 07:45PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 153.81B
Enterprise value 184.89B
Trailing P/E 23.56
Forward P/E 9.12
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.36
Price/book (mrq)4.71
Enterprise value/revenue 3.96
Enterprise value/EBITDA 9.58

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 311.65%
S&P500 52-week change 3-9.85%
52-week high 381.44
52-week low 362.90
50-day moving average 375.29
200-day moving average 374.46

Share statistics

Avg vol (3-month) 38.94M
Avg vol (10-day) 37.97M
Shares outstanding 52.13B
Implied shares outstanding 6N/A
Float 82.12B
% held by insiders 10.07%
% held by institutions 179.42%
Shares short (12 Jan 2023) 420.96M
Short ratio (12 Jan 2023) 42.29
Short % of float (12 Jan 2023) 40.99%
Short % of shares outstanding (12 Jan 2023) 40.99%
Shares short (prior month 14 Dec 2022) 424.88M

Dividends & splits

Forward annual dividend rate 42.28
Forward annual dividend yield 43.15%
Trailing annual dividend rate 32.16
Trailing annual dividend yield 32.96%
5-year average dividend yield 42.97
Payout ratio 470.36%
Dividend date 331 Jan 2023
Ex-dividend date 404 Jan 2023
Last split factor 21000000:951777
Last split date 306 Aug 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 14.29%
Operating margin (ttm)21.95%

Management effectiveness

Return on assets (ttm)6.13%
Return on equity (ttm)19.11%

Income statement

Revenue (ttm)46.74B
Revenue per share (ttm)21.70
Quarterly revenue growth (yoy)-3.50%
Gross profit (ttm)37.05B
Net income avi to common (ttm)6.68B
Diluted EPS (ttm)3.07
Quarterly earnings growth (yoy)3.90%

Balance sheet

Total cash (mrq)9.03B
Total cash per share (mrq)4.25
Total debt (mrq)40.17B
Total debt/equity (mrq)122.72
Current ratio (mrq)1.42
Book value per share (mrq)15.38

Cash flow statement

Operating cash flow (ttm)13.82B
Levered free cash flow (ttm)13.97B